J&J Buoyed by Tylenol, Branded Drugs While Devices Struggle

(Bloomberg) -- Johnson & Johnson reined in its outlook for the year after the coronavirus pandemic caused a first-quarter surge in demand for consumer brands like the pain reliever Tylenol but erod...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.